Colon cancer is one of the fastest-growing cancers worldwide. Despite meaningful advances in screening and detection, the number of cases continues to rise each year.

For many patients, treatment remains physically and emotionally demanding. Surgery often involves removing the malignancy, resecting part of the colon, and temporarily diverting the intestine to a colostomy bag. Even when reversible, patients may live with an ostomy for months—an experience that can significantly impact quality of life.

That’s why innovation in this space matters.

After leading the Series C round in SafeHeal, what stands out most is the real-world impact this work is already having on patient outcomes. A new clinical trial—featured in the video below—is evaluating a breakthrough device designed to potentially eliminate the need for a temporary ostomy and improve recovery.  Chris Richardson , CEO ,,,this is impressive !!

If you have even a passing interest in healthcare, medtech, or innovation, I strongly encourage you to take two minutes to watch this video. Progress like this is exactly why we invest!